1. Home/
  2. Compounds/
  3. decitabine:navitoclax (2:1 mol/mol)

decitabine:navitoclax (2:1 mol/mol)

Synonyms

SourcesNames Used
CTRPv2decitabine:navitoclax (2:1 mol/mol)
PharmacoGx decitabine:navitoclax (2:1 mol/mol)

Cell lines tested with decitabine:navitoclax (2:1 mol/mol)

831 cell lines have been tested with this compound, using data from 1 dataset(s).
A549 lung CTRPv23
DU-145 prostate CTRPv22
AsPC-1 pancreas CTRPv22
NCI-H1869 lung CTRPv22
CCF-STTG1 central nervous system CTRPv22
OAW-28 ovary CTRPv22
HeLa cervix CTRPv22
LOXIMVI haematopoietic and lymphoid tissue CTRPv22
NCI-H520 lung CTRPv22
MKN74 stomach CTRPv22
Download CSV

Tissues tested with decitabine:navitoclax (2:1 mol/mol)

25 tissues have been tested with this compound, using data from 1 dataset(s).
haematopoietic and lymphoid tissueCTRPv2151
lungCTRPv2139
N/ACTRPv248
large intestineCTRPv246
skinCTRPv246
central nervous systemCTRPv244
pancreasCTRPv241
ovaryCTRPv241
breastCTRPv237
stomachCTRPv233
Download CSV
Download Data as CSV

Top molecular features associated with response to decitabine:navitoclax (2:1 mol/mol)


Feature TypeStandardized
Nominal ANOVA
mRNA MBTD1 CTRPv2 AAC 0.33 3e-19
mRNA ZBED4 CTRPv2 AAC 0.31 4e-18
mRNA YPEL1 CTRPv2 AAC 0.27 9e-17
mRNA ZNF8 CTRPv2 AAC 0.26 1e-14
mRNA KMT5C CTRPv2 AAC 0.25 2e-14
mRNA ZNF766 CTRPv2 AAC 0.25 3e-14
mRNA GRIK5 CTRPv2 AAC 0.25 3e-14
mRNA ARHGAP33 CTRPv2 AAC 0.25 3e-14
mRNA SOX4 CTRPv2 AAC 0.23 6e-14
mRNA PRR36 CTRPv2 AAC 0.24 9e-14
Download CSV